Strategic Partnerships Potential sales opportunity through collaboration with external pharmaceutical and biotech partners already engaging with Jaeb Center, such as Alimera Sciences and Cecelia Health, to expand research programs, patient access, and outcomes-driven trials.

Diabetes and Eye Care Focus Target opportunities around diabetes management and ophthalmology trials, leveraging Jaeb's established specialization in type 1 diabetes and eye disorders to offer trial coordination, data management, patient recruitment, and remote monitoring services.

Clinical Trials Network Leverage Jaeb as a coordinating hub for multi-center trials to propose services that streamline site onboarding, protocol management, and regulatory compliance for sponsors seeking efficient, scalable trial execution.

Digital Platform Readiness Jaeb's tech stack including cloud, collaboration, and data tools (Azure, Microsoft 365, OpenAI, WordPress) indicates openness to digital trial enhancements, wearables integration, patient engagement platforms, and AI-driven data insights.

Funding Momentum Historical funding and grant activity from Helmsley Trust and partnerships with industry players signal a favorable environment for financing risk-sharing studies, enabling co-funded trials and augmenting sponsor ROI.